Hyperliquid Labs Executes $330 Million HYPE Token OTC Sale
Hyperliquid Labs has initiated the distribution of 3.75 million HYPE tokens, valued at approximately $330 million, as part of its over-the-counter (OTC) sale strategy. This move marks a significant step in the company’s token rollout, aimed primarily at institutional investors.
Details of the Token Distribution
As reported, the seven-day staking period for these tokens has concluded, allowing Hyperliquid Labs to shift the tokens to its spot balance. Instead of being offered on public exchanges, these tokens will be transferred through an OTC agreement with a yet-to-be-identified institutional buyer.
In the first round of distribution, 1.87 million HYPE tokens have already been allocated to five different wallets, with each receiving 375,000 tokens. This release accounts for 50% of the total OTC allocation, translating to a current market value of about $165 million.
Staking Activity Raises Questions
Observers monitoring on-chain transactions noted that one of the wallets involved in the distribution has staked its tokens with the Unit x Hyperliquid Strategies Validator. This action may provide clues regarding the identity of the institutional recipient, although no official confirmations have been made.
Upcoming Token Releases
Hyperliquid Labs plans to continue the distribution process, with the remaining 1.87 million HYPE tokens expected to be exchanged under the same OTC framework.
This development signifies an important phase for Hyperliquid Labs and the growing interest in the HYPE token within the institutional investment landscape. Investors should remain vigilant and conduct thorough research before engaging in any investment activities.
